Centre should ensure no illegal activity at NEIGRIHMS: Sangma

Image
Press Trust of India Shillong
Last Updated : Oct 25 2019 | 6:45 PM IST

Meghalaya Chief Minister Conrad K Sangma on Friday said the Centre should ensure that there is no "illegal activity" in the North Eastern Indira Gandhi Regional Institute of Health & Medical Sciences (NEIGRIHMS).

NEIGRIHMS has been embroiled in controversy following allegations by its director D M Thappa against the cardiology department head for not cooperating with the administration in making treatment of poor patients affordable.

Thappa had also said complaints were received regarding the high price of heart stents availed from local vendors, instead of the AMRIT pharmacy at the institute.

"As a concerned citizen and as the head of the state, if there is any kind of illegal activity that is going on (NEIGRIHMS), it must be enquired into by the government of India," Sangma told reporters here.

He added that the state government does not have much say in the affairs of the central institute except to flag issues to the Union government.

Earlier, the NEIGRIHMS director had sought the intervention of Prime Minister Narendra Modi for a CBI inquiry into the alleged nexus between the cardiology department and a private pharmacy.

The Meghalaya Pradesh Youth Congress (MPYC) and the Civil Society Women's Organisation (CSWO) have also demanded a probe by the central investigating agency.

In May, authorities at the institute had seized various cardiology stents, worth over Rs 20 lakh, from a vendor in the premises of the hospital.

The stents were allegedly sold at a higher price than the capped rate fixed by the ministry at Rs 30,000.

The Cardiology department head, however, denied the allegations and claimed that the Amrit pharmacy had indicated about the non-availability of stents.

NEIGRIHMS is the only super specialty hospital in the northeast region.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 25 2019 | 6:45 PM IST

Next Story